Intellia Therapeutics Newsroom

Insiders At Intellia Therapeutics Sold US$975k In Stock, Alluding To Potential Weakness

Simply Wall StJan 20 05:47 ET

Intellia Loses 21.6% in a Week: How Should You Play the Stock?

Zacks Jan 17 13:00 ET

BofA Securities Maintains Intellia Therapeutics(NTLA.US) With Buy Rating, Cuts Target Price to $45

Moomoo NewsJan 14 10:32 ET · Ratings

Goldman Sachs Maintains Intellia Therapeutics(NTLA.US) With Hold Rating, Cuts Target Price to $12

Moomoo NewsJan 14 10:32 ET · Ratings

Express News | Goldman Sachs Maintains Neutral on Intellia Therapeutics, Lowers Price Target to $12

BenzingaJan 14 09:10 ET

A Quick Look at Today's Ratings for Intellia Therapeutics(NTLA.US), With a Forecast Between $40 to $45

Moomoo NewsJan 14 08:00 ET · Ratings

Analysts Conflicted on These Healthcare Names: Rocket Pharmaceuticals (RCKT), CareDx (CDNA) and Intellia Therapeutics (NTLA)

TipRanksJan 14 06:30 ET · Ratings

Oppenheimer Maintains Outperform on Intellia Therapeutics, Lowers Price Target to $40

BenzingaJan 13 11:08 ET · Ratings

Express News | Intellia Therapeutics Inc : Jefferies Cuts Target Price to $86 From $128

ReutersJan 13 00:15 ET

Express News | Intellia Therapeutics Inc : Oppenheimer Cuts Target Price to $40 From $60

ReutersJan 13 00:04 ET

BofA Securities Maintains Intellia Therapeutics(NTLA.US) With Buy Rating, Maintains Target Price $50

Moomoo NewsJan 11 11:31 ET · Ratings

Strategic Focus and Financial Resilience: Terence Flynn's Positive Outlook on Intellia Therapeutics

TipRanksJan 11 10:36 ET

Barclays Maintains Intellia Therapeutics(NTLA.US) With Buy Rating, Maintains Target Price $55

Moomoo NewsJan 11 10:32 ET · Ratings

Analysts' Top Healthcare Picks: Inozyme Pharma (INZY), Intellia Therapeutics (NTLA)

TipRanksJan 11 10:30 ET · Ratings

A Quick Look at Today's Ratings for Intellia Therapeutics(NTLA.US), With a Forecast Between $29 to $60

Moomoo NewsJan 11 08:00 ET · Ratings

Intellia Therapeutics Price Target Lowered to $60 From $70 at Wells Fargo

Yahoo FinanceJan 11 07:36 ET

Cathie Wood's Ark Invest Loads Up On Intellia Therapeutics Which Laid Off Over A Quarter Of Its Workforce

BenzingaJan 11 04:33 ET

Peering Into Intellia Therapeutics's Recent Short Interest

BenzingaJan 10 15:45 ET

Intellia Therapeutics Shares Are Trading Lower After the Company Announced a Strategic Reorganization to Prioritize Late-stage Programs NTLA-2002 and Nexiguran Ziclumeran.

BenzingaJan 10 15:15 ET

Express News | Intellia Therapeutics Shares Are Trading Lower After the Company Announced a Strategic Reorganization to Prioritize Late-stage Programs NTLA-2002 and Nexiguran Ziclumeran

BenzingaJan 10 15:15 ET